Nicola Mikulcik Ohrner
Corporate Officer/Principal at FORMYCON AG
Profile
Nicola Mikulcik Ohrner is currently holding three positions in the biotech industry.
He is the Chief Executive Officer of bioeq GmbH, a Director at Bioeq AG, and the Chief Business Officer at Formycon AG.
Nicola Mikulcik Ohrner active positions
Companies | Position | Start |
---|---|---|
FORMYCON AG | Corporate Officer/Principal | 01/06/2022 |
bioeq GmbH
bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany. | Chief Executive Officer | - |
Bioeq AG
Bioeq AG Pharmaceuticals: MajorHealth Technology Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland. | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
FORMYCON AG | Health Technology |
Private companies | 2 |
---|---|
bioeq GmbH
bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany. | Health Technology |
Bioeq AG
Bioeq AG Pharmaceuticals: MajorHealth Technology Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Nicola Mikulcik Ohrner